

ANI Pharmaceuticals (NASDAQ:ANIP) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been...
You can purchase shares of ANI Pharmaceuticals (NASDAQ:ANIP) through any online brokerage.
Other companies in ANI Pharmaceuticals’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
ANI Pharmaceuticals has a consensus price target of $93.75.
The stock price for ANI Pharmaceuticals (NASDAQ: ANIP) is $70.66 last updated November 5, 2026 at 1:48 PM EST.
There are no upcoming dividends for ANI Pharmaceuticals.
ANI Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for ANI Pharmaceuticals.
ANI Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology,...